Skelly’s Bar in Ballymahon is to play host to a special fundraising night in aid of the Friedeichs Ataxia Society of Ireland on Friday, June 13 next with a host of excellent local acts performing on the occasion. Friedeichs Ataxia is a rare genetic and progressive disorder of the central...
Latest News
WASHINGTON, D.C. — Muscular dystrophy is one of the most common genetic disorders. One in every 3,500 baby boys is diagnosed with the condition. The most devastating type — Duchenne muscular dystrophy — slowly robs kids of their muscles, and they rarely live past age 20. Researchers say they’ve made...
Tel Aviv, Israel – Autism Spectrum Disorder (ASD), a neurodevelopmental condition characterized by decreased social communication and repetitive behaviors, has long intrigued scientists seeking to unravel its underlying mechanisms. Researchers from the Azrieli Faculty of Medicine of Bar-Ilan University have now identified a potential link between ASD and the composition...
– Baricitinib met the primary endpoint of hair regrowth across both dosing regimens – There are currently no FDA-approved treatments for AA INDIANAPOLIS – Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today top-line results from BRAVE-AA2, a Phase 3 study evaluating the efficacy and safety of...
Ridgefield, Conn. – New York Yankees legend and Latin Grammy-nominee Bernie Williams has teamed up with award-winning actress, musician and TV producer Queen Latifah, music duo The Bacon Brothers, singer and composer Paul Shaffer, and other notable judges, to vote on lyrics submitted by the public for the Breathless® Ballad...
Chiba, Japan – Pulmonary aspergillosis—a group of infectious respiratory diseases caused by various species of the fungus Aspergillus fumigatus—has a significant mortality rate across the globe. Currently, the first-line antifungal therapy in patients with chronic pulmonary aspergillosis and invasive pulmonary aspergillosis is azoles, which belong to a class of antifungal...
COPENHAGEN, Denmark – Bavarian Nordic A/S (OMX: BAVA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted accelerated assessment for the upcoming Marketing Authorisation Application (MAA) for CHIKV VLP, the Company’s investigational chikungunya vaccine. The accelerated assessment, which is...
WAYNE, N.J. and EMERYVILLE, Calif. — Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar(R) (sorafenib) tablets in patients with non-squamous non-small cell lung cancer (NSCLC) who have failed two or...
Berlin – Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. today announced that the companies have begun enrolling patients in an international Phase III trial to evaluate Nexavar® (sorafenib) tablets in patients with non-squamous non-small cell lung cancer (NSCLC) who have failed two or three previous treatments. “Nexavar has proven efficacy...
Berlin — Bayer Schering Pharma AG, Germany, has completed its first global Phase II study analyzing the sensitivity and specificity of BAY 94-9172 (AV1/ZK) using positron emission tomography (PET) in patients with probable Alzheimer’s disease compared to healthy volunteers. BAY 94-9172 binds to the beta amyloid protein in the brain,...